CN103087169B - Preparation method of antitumor wheat germ proteins - Google Patents
Preparation method of antitumor wheat germ proteins Download PDFInfo
- Publication number
- CN103087169B CN103087169B CN201310046768.8A CN201310046768A CN103087169B CN 103087169 B CN103087169 B CN 103087169B CN 201310046768 A CN201310046768 A CN 201310046768A CN 103087169 B CN103087169 B CN 103087169B
- Authority
- CN
- China
- Prior art keywords
- wheat germ
- water
- protein
- low
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
一种小麦胚芽抗肿瘤蛋白的制备工艺,包括:(1)取新鲜小麦胚芽进行低温脱脂、粉碎处理,而后以水作为溶剂进行提取操作;(2)去除步骤(1)所获混合提取液中的不溶物,并以硫酸铵对所获上清液进行分步分级沉淀,其后分离出沉淀物,再将沉淀物复溶于水中进行透析处理,之后依次进行浓缩、冷冻干燥处理,获得小麦胚芽水溶性蛋白;(3)将小麦胚芽水溶性蛋白溶于缓冲液中,并依次进行离子交换层析和凝胶过滤层析处理,获得目标产物。本发明以水作为提取液,天然健康,不会导致所获产物中留存有毒物质,利于提升所获产物的生理活性,且工艺简单,成本低廉,同时所获产品对人乳腺癌细胞株的生长具有显著的增值抑制活性,而对正常细胞的毒性很小。
A preparation process of wheat germ anti-tumor protein, comprising: (1) taking fresh wheat germ for low-temperature degreasing and crushing treatment, and then extracting with water as a solvent; (2) removing the mixed extract obtained in step (1) Insoluble matter, and the obtained supernatant was precipitated step by step with ammonium sulfate, and then the precipitate was separated, and then the precipitate was redissolved in water for dialysis treatment, followed by concentration and freeze-drying in turn to obtain wheat Germ water-soluble protein; (3) dissolving the wheat germ water-soluble protein in buffer, and performing ion exchange chromatography and gel filtration chromatography in sequence to obtain the target product. The present invention uses water as the extraction solution, which is natural and healthy, does not cause toxic substances to remain in the obtained product, is beneficial to improving the physiological activity of the obtained product, and has a simple process and low cost. It has significant proliferation inhibitory activity, but has little toxicity to normal cells.
Description
技术领域technical field
本发明涉及一种抗肿瘤蛋白的制备方法,特别涉及一种小麦胚芽抗肿瘤蛋白的制备方法,属于小麦精深加工技术。The invention relates to a preparation method of anti-tumor protein, in particular to a preparation method of wheat germ anti-tumor protein, which belongs to the deep processing technology of wheat.
背景技术Background technique
小麦胚芽是面粉加工的副产物,我国的小麦粉生产量巨大,因此小麦胚芽的产量也很可观。小麦胚芽除了含有较高的优质蛋白外,还含有维生素E、镁、泛酸、磷、硫胺素等,是一种难得的天然健康食品资源。Wheat germ is a by-product of flour processing. The production of wheat flour in my country is huge, so the output of wheat germ is also considerable. In addition to high-quality protein, wheat germ also contains vitamin E, magnesium, pantothenic acid, phosphorus, thiamine, etc. It is a rare natural healthy food resource.
人们从植物中发现了很多种抗肿瘤活性蛋白,国外有研究者从小麦胚芽发酵提取物中分离得到多肽类成分,并证明其具有抗肿瘤效果。小麦胚芽蛋白和多肽的抗氧化、抗衰老、抗疲劳等生理活性得到国内外学者的广泛关注,其抗肿瘤活性报道很少。有报道认为小麦胚芽水溶性提取物能明显抑制S-180肉瘤的生长,同时提高荷瘤小鼠免疫器官的重量,并可使荷瘤小鼠的腹腔巨噬细胞活性得到恢复,提高小鼠巨噬细的吞噬能力,且水提取物对MDA-MB231细胞生长有明显的抑制效应,但是究竟是何种成分起作用,并不清楚。由于脂溶性提取物、盐溶性提取物及发酵提取物中不可避免的溶剂残留和活性成分不明确,给以小麦胚芽为原料开发抗肿瘤保健食品或药物带来一定的不确定性,并且不能高效地实现小麦胚芽资源的增值转化。Many kinds of anti-tumor active proteins have been found in plants. Foreign researchers have isolated polypeptide components from wheat germ fermentation extracts and proved that they have anti-tumor effects. The physiological activities of wheat germ protein and polypeptide, such as anti-oxidation, anti-aging, and anti-fatigue, have attracted extensive attention from scholars at home and abroad, but there are few reports on its anti-tumor activity. It has been reported that the water-soluble extract of wheat germ can significantly inhibit the growth of S-180 sarcoma, increase the weight of immune organs in tumor-bearing mice, restore the activity of peritoneal macrophages in tumor-bearing mice, and improve the macrophages of mice. The phagocytosis of phagocytic cells, and the water extract has a significant inhibitory effect on the growth of MDA-MB231 cells, but it is not clear which components play a role. Due to the unavoidable solvent residues and unclear active ingredients in fat-soluble extracts, salt-soluble extracts and fermented extracts, it brings certain uncertainty to the development of anti-tumor health food or drugs using wheat germ as raw materials, and it cannot be efficiently Realize the value-added transformation of wheat germ resources efficiently.
发明内容Contents of the invention
本发明的目的主要在于提供一种小麦胚芽抗肿瘤蛋白的制备工艺,其以水作为提取液,天然健康,不仅不会导致所获小麦胚芽蛋白中留存有毒有害物质,还有利于提升所获小麦胚芽蛋白的多种生理活性,使其对人乳腺癌细胞株MDA-MB231的生长表现出显著增殖抑制活性以及对正常细胞细胞的低毒性,从而克服了现有技术中的不足。The purpose of the present invention is mainly to provide a preparation process of wheat germ anti-tumor protein, which uses water as the extract, which is natural and healthy, not only does not cause toxic and harmful substances to be retained in the obtained wheat germ protein, but also helps to improve the quality of the obtained wheat germ protein. The multiple physiological activities of the germ protein make it exhibit significant proliferation inhibitory activity on the growth of human breast cancer cell line MDA-MB231 and low toxicity to normal cells, thereby overcoming the deficiencies in the prior art.
为实现上述发明目的,本发明采用的技术方案如下:For realizing above-mentioned purpose of the invention, the technical scheme that the present invention adopts is as follows:
一种小麦胚芽抗肿瘤蛋白的制备工艺,包括:A preparation process of wheat germ anti-tumor protein, comprising:
(1)取新鲜小麦胚芽进行低温脱脂、粉碎处理,而后以水作为溶剂进行提取操作;(1) Take fresh wheat germ and carry out low-temperature degreasing and crushing treatment, and then use water as a solvent to carry out extraction operation;
(2)去除步骤(1)所获混合提取液中的不溶物,并以硫酸铵对所获上清液进行分级沉淀,其后分离出沉淀物,再将沉淀物复溶于水中进行透析处理,之后依次进行浓缩、冷冻干燥处理,获得小麦胚芽水溶性蛋白;(2) Remove the insoluble matter in the mixed extract obtained in step (1), and carry out fractional precipitation on the obtained supernatant with ammonium sulfate, then separate the precipitate, and then redissolve the precipitate in water for dialysis treatment , followed by concentration and freeze-drying to obtain wheat germ water-soluble protein;
(3)将所述小麦胚芽水溶性蛋白溶于缓冲液中,并依次进行离子交换层析和凝胶过滤层析处理,获得目标产物。(3) dissolving the wheat germ water-soluble protein in a buffer solution, and performing ion exchange chromatography and gel filtration chromatography in sequence to obtain the target product.
作为较为优选的实施方案之一,步骤(1)包括:以低温萃取方式对小麦胚芽进行脱脂处理至小麦胚芽粕中的残油值在2.0wt%以下;As one of the more preferred embodiments, the step (1) includes: degreasing the wheat germ by means of low-temperature extraction until the residual oil value in the wheat germ meal is below 2.0 wt %;
所述低温萃取包括超临界二氧化碳萃取、四号溶剂加压萃取或有机溶剂低温萃取。The low-temperature extraction includes supercritical carbon dioxide extraction, No. 4 solvent pressure extraction or organic solvent low-temperature extraction.
所述有机溶剂可选自但不限于正己烷、石油醚或丙酮。The organic solvent may be selected from but not limited to n-hexane, petroleum ether or acetone.
所述低温是指温度在40℃以下。The low temperature refers to a temperature below 40°C.
作为较为优选的实施方案之一,步骤(1)包括:将脱脂后的小麦胚芽粕粉碎后过80-100目筛获得脱脂麦胚粉,其后按照10∶1(v/w)的液料比将水与脱脂麦胚粉混合,并搅拌提取,形成混合提取液。As one of the more preferred embodiments, step (1) includes: crushing the defatted wheat germ meal and passing it through a 80-100 mesh sieve to obtain defatted wheat germ powder, and then using a 10:1 (v/w) liquid feed Mix water with defatted wheat germ flour and stir to extract to form a mixed extract.
作为较为优选的实施方案之一,步骤(2)包括:对步骤(1)所获混合提取液进行离心处理,分离出其中的不溶物,同时收集上清液,并分步缓慢加入硫酸铵至上清液中停止析出沉淀物,而后离心分离出所述沉淀物,再将沉淀物复溶于水中,之后依次进行透析、浓缩和冷冻干燥处理。As one of the more preferred embodiments, step (2) includes: centrifuging the mixed extract obtained in step (1), separating the insoluble matter therein, collecting the supernatant at the same time, and slowly adding ammonium sulfate step by step to the top The precipitation of the precipitate stops in the clear liquid, and then the precipitate is separated by centrifugation, and then the precipitate is redissolved in water, followed by dialysis, concentration and freeze-drying in sequence.
前述的“分步”是指先缓慢添加硫酸铵至相对较低的饱和度状态,将盐析出的蛋白分离除去,然后再添加硫酸铵达到相对较高的饱和度状态,再离心分离出盐析蛋白,藉此得到比较纯的目标蛋白,剔除杂蛋白,这也是分步阶梯盐析。The aforementioned "step-by-step" refers to slowly adding ammonium sulfate to a relatively low saturation state, separating and removing the salted-out protein, and then adding ammonium sulfate to a relatively high saturation state, and then centrifuging to separate the salted-out protein , so as to obtain a relatively pure target protein and remove impurity proteins, which is also a step-by-step salting-out.
尤为优选的,步骤(2)还包括:将所述不溶物再次以水进行提取操作,其后再次离心分离出不溶物,并再次收集上清液,之后加入硫酸铵进行分步分级沉淀,所述分步分级沉淀的过程包括:Particularly preferably, step (2) also includes: extracting the insoluble matter with water again, then centrifuging again to separate the insoluble matter, and collecting the supernatant again, and then adding ammonium sulfate for step-by-step fractional precipitation, so that The process of step-by-step fractionation precipitation includes:
室温条件下,加入硫酸铵到上清液至15-20%饱和度,析出蛋白,离心弃之,收集上清液再加入硫酸铵至20-40%饱和度,收集所得析出蛋白组分。At room temperature, add ammonium sulfate to the supernatant to 15-20% saturation, precipitate protein, centrifuge, collect the supernatant, add ammonium sulfate to 20-40% saturation, and collect the precipitated protein fraction.
尤为优选的,步骤(2)中的离心操作均采用低温离心操作,所述低温离心操作的条件包括:转速为8000r/min以上,温度在0~4℃,时间为20min以上。Particularly preferably, the centrifugation in step (2) is performed at a low temperature, and the conditions of the low temperature centrifugation include: the rotation speed is above 8000r/min, the temperature is 0-4°C, and the time is above 20min.
作为较为优选的实施方案之一,步骤(3)包括:将所述小麦胚芽水溶性蛋白溶于Tris-HCl缓冲液中,并依次过DEAE-Sepharose FF离子交换层析柱和Superdex20010/300_GL凝胶过滤层析柱,获得目标产物。As one of more preferred embodiments, step (3) comprises: described wheat germ water-soluble protein is dissolved in Tris-HCl damping fluid, and pass through DEAE-Sepharose FF ion-exchange chromatography column and Superdex20010/300-GL gel successively Filter the chromatographic column to obtain the target product.
作为较为优选的实施方案之一,步骤(3)中所述离子交换层析处理及凝胶过滤层析处理的条件包括:以缓冲液作为洗脱液,并且所述洗脱液的流速分别为1.0~2.0mL/min、0.2~0.5mL/min。As one of the more preferred embodiments, the conditions of the ion exchange chromatography treatment and gel filtration chromatography treatment described in step (3) include: using a buffer as the eluent, and the flow rate of the eluent is respectively 1.0~2.0mL/min, 0.2~0.5mL/min.
作为较为优选的实施方案之一,所述小麦胚芽抗肿瘤蛋白的制备工艺具体包括:As one of the more preferred embodiments, the preparation process of the wheat germ anti-tumor protein specifically includes:
(1)取除杂后的新鲜小麦胚芽进行低温脱脂,再将脱脂后的小麦胚芽粕风干后过60~80目筛,除去附着的细粉,而后粉碎过80~100目筛,获得脱脂麦胚粉;(1) Take the fresh wheat germ after removing impurities and carry out low-temperature degreasing, then air-dry the defatted wheat germ meal and pass it through a 60-80 mesh sieve to remove the attached fine powder, and then crush it through a 80-100 mesh sieve to obtain defatted wheat germ germ powder;
(2)按8∶1~12∶1(v/w)的液料比将水与脱脂麦胚粉混合,以180~220r/min的速度振荡提取3h以上,其后低温离心,收集上清液,并将分离出的固形物与水按照4∶1~6∶1的液料比提取1h以上,之后再次低温离心,合并上清液,并分步缓慢加入硫酸铵至达到饱和状态,而后静置3h以上,低温离心出沉淀,加水复溶后装入透析袋中,置于4℃以下的水中透析24h以上,浓缩后冷冻干燥,制得小麦胚芽水溶性蛋白;(2) Mix water and defatted wheat germ flour at a liquid-to-material ratio of 8:1-12:1 (v/w), shake and extract at a speed of 180-220r/min for more than 3 hours, then centrifuge at low temperature, and collect the supernatant liquid, and extract the separated solid matter and water according to the ratio of liquid to material of 4:1 to 6:1 for more than 1 h, then centrifuge again at low temperature, combine the supernatant, and slowly add ammonium sulfate step by step until reaching saturation, and then Stand still for more than 3 hours, centrifuge at low temperature to remove the precipitate, reconstitute with water, put it into a dialysis bag, place it in water below 4°C for dialysis for more than 24 hours, concentrate and freeze-dry to obtain the wheat germ water-soluble protein;
(3)将小麦胚芽水溶性蛋白溶解于pH值7.4~8.0、10~20mmol/LTris-HCl缓冲液中,且使形成的小麦胚芽水溶性蛋白溶液的浓度为5~10mg/mL,再上样于经过上样缓冲液平衡的DEAE-Sepharose FF阴离子交换柱,并以含0~0.8mol/LNaCl的pH值7.4~8.0、10~20mmol/LTris-HCl缓冲液为洗脱剂按照1.0~2.0mL/min的流速进行洗脱,收集洗脱物置于4℃以下的水中透析24h以上,冷冻干燥,分离得到抗肿瘤活性组分;(3) Dissolve the wheat germ water-soluble protein in pH 7.4-8.0, 10-20mmol/LTris-HCl buffer solution, and make the concentration of the formed wheat germ water-soluble protein solution 5-10mg/mL, and then load the sample On the DEAE-Sepharose FF anion-exchange column equilibrated with loading buffer, and pH 7.4-8.0, 10-20mmol/L Tris-HCl buffer containing 0-0.8mol/L NaCl as the eluent, according to 1.0-2.0mL /min flow rate for elution, collect the eluate and dialyze in water below 4°C for more than 24 hours, freeze-dry, and separate the anti-tumor active components;
(4)将抗肿瘤活性组分溶解于pH值7.4、含有50~150mmol/LNaCl,30~60mmol/L磷酸盐缓冲液,且使形成的抗肿瘤活性组分溶液的浓度为以2~4mg/mL上样于经过平衡的superdex20010/300GL凝胶柱,用缓冲液按照0.4mL/min的流速洗脱,获得目标产物。(4) Dissolving the anti-tumor active component in a pH value of 7.4, containing 50-150mmol/L NaCl, 30-60mmol/L phosphate buffer, and making the concentration of the formed anti-tumor active component solution be 2-4mg/L mL was loaded on the equilibrated superdex20010/300GL gel column, and eluted with buffer at a flow rate of 0.4mL/min to obtain the target product.
作为较为优选的实施方案之一,步骤(2)中0℃下硫酸铵的饱和度为20wt%~40wt%。As one of the more preferred embodiments, the saturation of ammonium sulfate at 0° C. in step (2) is 20 wt % to 40 wt %.
与现有技术相比,本发明至少具有如下有益效果:Compared with the prior art, the present invention has at least the following beneficial effects:
(1)本发明以水作为溶剂,天然健康,不仅不会导致所获小麦胚芽蛋白中留存毒有害物质,还有利于提升所获小麦胚芽蛋白的多种生理活性,并且本发明工艺简单,成本低廉,易于规模化应用;(1) The present invention uses water as a solvent, which is natural and healthy, not only does not cause toxic and harmful substances to be retained in the obtained wheat germ protein, but also helps to improve various physiological activities of the obtained wheat germ protein, and the process of the present invention is simple and low cost. Inexpensive and easy to scale up;
(2)采用本发明制备得到的产品为白色絮状,单一组分,对人乳腺癌细胞株MDA-MB231的生长具有显著的增值抑制活性,IC50值为22.33μg/mL,而且对正常细胞的毒性很小。(2) The product prepared by adopting the present invention is white flocculent, single component, and has significant proliferation inhibitory activity to the growth of human breast cancer cell line MDA-MB231, and the IC50 value is 22.33 μ g/mL, and to normal cells Very little toxicity.
(3)本发明为小麦胚芽的深度开发和利用提供了有效途径。(3) The invention provides an effective way for the deep development and utilization of wheat germ.
附图说明Description of drawings
图1是本发明一较佳实施方案中一种小麦胚芽抗肿瘤蛋白的制备工艺流程图;Fig. 1 is a process flow diagram for the preparation of a wheat germ anti-tumor protein in a preferred embodiment of the present invention;
图2是本发明一较佳实施方案中WGWSP的DEAE-Sepharose FF层析图谱,其中:WGWSP1是0mol/L NaCl洗脱峰,WGWSP2是0.3mol/L NaCl洗脱峰,WGWSP3是0.8mol/L NaCl洗脱峰;Fig. 2 is the DEAE-Sepharose FF chromatogram of WGWSP in a preferred embodiment of the present invention, wherein: WGWSP1 is 0mol/L NaCl elution peak, WGWSP2 is 0.3mol/L NaCl elution peak, WGWSP3 is 0.8mol/L NaCl elution peak;
图3是本发明一较佳实施方案中Superdex20010/300GL凝胶过滤层析图谱。Fig. 3 is a gel filtration chromatogram of Superdex20010/300GL in a preferred embodiment of the present invention.
图4是本发明一较佳实施方案中WGWSP11高效液相图谱;Fig. 4 is WGWSP11 high performance liquid phase collection of illustrative plates in a preferred embodiment of the present invention;
图5是本发明一较佳实施方案中所获WGWSP11的SDS-PAGE考马斯亮蓝染色图,其中1为加巯基乙醇,M为标准蛋白,2为不加巯基乙醇。Fig. 5 is an SDS-PAGE Coomassie Brilliant Blue staining image of WGWSP11 obtained in a preferred embodiment of the present invention, wherein 1 means adding mercaptoethanol, M means standard protein, and 2 means not adding mercaptoethanol.
具体实施方式Detailed ways
本发明的一个方面旨在提供一种小麦胚芽抗肿瘤蛋白的制备工艺,其可以包括:以新鲜小麦胚芽为原料,通过低温萃取(如,超临界二氧化碳萃取,四号溶剂加压萃取,有机溶剂低温萃取)脱脂,粉碎,震荡水提取,离心分离,收集上清液,加硫酸铵分级沉淀,离心分离,收集沉淀,复溶,透析,冷冻干燥得到小麦胚芽水溶性蛋白质(WGWSP),WGWSP溶解于缓冲液中上DEAE-Sepharose FF离子交换层析住,分离得到抗肿瘤活性组分(WGWSP1),(WGWSP1)溶解于缓冲液中上Superdex20010/300GL凝胶过滤层析柱,得到目标产物(抗肿瘤活性组分,WGWSP11)。One aspect of the present invention aims to provide a preparation process of wheat germ anti-tumor protein, which may include: using fresh wheat germ as raw material, through low-temperature extraction (such as supercritical carbon dioxide extraction, No. 4 solvent pressure extraction, organic solvent Low-temperature extraction) degreasing, pulverization, shaking water extraction, centrifugation, collecting supernatant, adding ammonium sulfate fractional precipitation, centrifugation, collecting precipitate, redissolving, dialysis, freeze-drying to obtain wheat germ water-soluble protein (WGWSP), WGWSP dissolved Go up DEAE-Sepharose FF ion-exchange chromatography in the buffer solution, separate and obtain the antitumor active component (WGWSP1), (WGWSP1) is dissolved in the buffer solution and go on the Superdex20010/300GL gel filtration chromatography column, obtain the target product (anti-tumor active component (WGWSP1) Tumor Active Component, WGWSP11).
作为较佳的具体应用方案之一,参阅图1-图5,该制备工艺可以包括:As one of the preferred specific application schemes, referring to Fig. 1-Fig. 5, the preparation process may include:
(1)小麦胚芽水溶性蛋白质WGWSP的制备:除杂后的新鲜小麦胚芽加入正己烷浸泡脱脂,间隔2小时更换一次正己烷,直至滴在滤纸上的上清液风干后无油印为止。将脱脂后的麦胚风干后过筛除去附着的细粉,经摇摆式高速中药粉碎机粉碎过筛得到细粉即为脱脂麦胚粉。(1) Preparation of wheat germ water-soluble protein WGWSP: After removing impurities, fresh wheat germ was soaked in n-hexane to degrease, and n-hexane was replaced every 2 hours until the supernatant dripped on the filter paper was air-dried and free of oil marks. Air-dry the degreased wheat germ, sieve to remove the attached fine powder, pulverize and sieve with a swing-type high-speed traditional Chinese medicine grinder to obtain the fine powder, which is defatted wheat germ powder.
(2)以水为提取溶剂,料液比1∶10,在气浴振荡器上以180~220r/min的速度提取3h,然后低温离心,残渣用一半的水提取1h,相同条件离心,合并上清液,缓缓向其中加入硫酸铵固体进行分步分级沉淀,然后低温离心,沉淀加水复溶,然后将其装入透析袋中,置于4℃水中透析24h,浓缩后冷冻干燥,制得WGWSP;(2) Use water as the extraction solvent, the ratio of solid to liquid is 1:10, extract on an air bath oscillator at a speed of 180-220r/min for 3h, then centrifuge at low temperature, extract the residue with half of the water for 1h, centrifuge under the same conditions, and combine To the supernatant, slowly add ammonium sulfate solid to carry out step-by-step precipitation, then centrifuge at low temperature, redissolve the precipitate with water, then put it into a dialysis bag, place it in 4°C water for dialysis for 24 hours, freeze-dry after concentration, and prepare Get WGWSP;
(3)DEAE-SepharoseFF离子交换层析及各层析组分的抗肿瘤活性检测(3) DEAE-SepharoseFF ion exchange chromatography and detection of antitumor activity of each chromatographic component
小麦胚芽水溶性蛋白冷冻干燥样品WGWSP溶解于pH8.0,20mmol/LTris-HCl缓冲液中,WGWSP浓度为5~10mg/mL,通过0.22μm的微孔滤膜后,上样于经过上样缓冲液平衡的DEAE-Sepharose FF阴离子交换柱,依次用0、0.3、0.8mol/LNaCl的pH8.0、20mmol/LTris-HCl缓冲液为洗脱剂进行洗脱,流速为1.6mL/min,HD-5检测器检测,检测波长280nm,自动收集器5min收集一管。得到3个组分WGWSP1、WGWSP2、WGWSP3,置于4℃水中透析24h脱盐,冷冻干燥,分离得到抗肿瘤活性组分WGWSP1;WGWSP, a freeze-dried sample of wheat germ water-soluble protein, was dissolved in pH 8.0, 20mmol/LTris-HCl buffer solution, the concentration of WGWSP was 5-10mg/mL, passed through a 0.22μm microporous membrane, and loaded on the Liquid-balanced DEAE-Sepharose FF anion-exchange column was eluted with 0, 0.3, 0.8mol/L NaCl pH8.0, 20mmol/LTris-HCl buffer as the eluent, the flow rate was 1.6mL/min, HD- 5 detector detection, the detection wavelength is 280nm, and the automatic collector collects one tube every 5 minutes. The three components WGWSP1, WGWSP2, and WGWSP3 were obtained, which were dialyzed in water at 4°C for 24 hours for desalination, freeze-dried, and the anti-tumor active component WGWSP1 was isolated;
抗肿瘤活性检测:采用人乳腺癌细胞株MDA-MB231作为受试细胞株,MTT法测定WGWSP1、WGWSP2、WGWSP3的抗肿瘤活性,经检测可知,WGWSP1对人乳腺癌细胞株MDA-MB231有较强的增殖抑制活性。Anti-tumor activity detection: Human breast cancer cell line MDA-MB231 was used as the test cell line, and the anti-tumor activity of WGWSP1, WGWSP2, and WGWSP3 was determined by MTT method. The test shows that WGWSP1 has a strong effect on human breast cancer cell line MDA-MB231. growth inhibitory activity.
(4)Superdex20010/300GL凝胶过滤层析及各层析组分的抗肿瘤活性检测(4) Superdex20010/300GL gel filtration chromatography and detection of antitumor activity of each chromatographic component
将WGWSP1以2~4mg/mL溶解于pH7.4,含有150mmol/LNaCl,50mmol/L磷酸盐缓冲液,通过0.22μm的微孔滤膜后,上样于经过平衡的AKTApurifier10蛋白纯化系统上的superdex20010/300GL凝胶柱,用缓冲液洗脱,流速0.4mL/min,收集各峰检测其抗肿瘤活性得到活性峰WGWSP12。Dissolve WGWSP1 at 2-4mg/mL in pH7.4, containing 150mmol/L NaCl, 50mmol/L phosphate buffer, pass through a 0.22μm microporous membrane, and load the sample on superdex20010 on the balanced AKTApurifier10 protein purification system /300GL gel column, eluted with buffer, flow rate 0.4mL/min, collected each peak to detect its anti-tumor activity to obtain the active peak WGWSP12.
抗肿瘤活性检测:采用人乳腺癌细胞株MDA-MB231作为受试细胞株,MTT法测定WGWSP11、WGWSP12、WGWSP13、WGWSP14的抗肿瘤活性,经检测可知,WGWSP11对人乳腺癌细胞株MDA-MB231有较强的增殖抑制活性,通过对正常细胞人胚肾细胞HEK-293的增殖抑制活性测定,发现WGWSP11对正常细胞IC50为191.719μg/mL,远远大于对MDA-MB231的IC50值22.33μg/mL。Anti-tumor activity detection: Human breast cancer cell line MDA-MB231 was used as the test cell line, and the anti-tumor activity of WGWSP11, WGWSP12, WGWSP13, and WGWSP14 was determined by MTT method. The test shows that WGWSP11 has a certain effect on human breast cancer cell line MDA-MB231. Strong anti-proliferation activity. By measuring the anti-proliferation activity of human embryonic kidney cells HEK-293, it was found that the IC 50 of WGWSP11 against normal cells was 191.719 μg/mL, which was far greater than the IC 50 value of MDA-MB231, which was 22.33 μg /mL.
(5)WGWSP11纯度鉴定(5) Purity identification of WGWSP11
采用SEC-HPLC进行WGWSP12的纯度鉴定,使用了Hitachi高效液相系统和Shodex KW-804蛋白柱。柱子的洗脱极限为1,000,000Da,分离柱效大于20,000Da,流动相为50mmol/L的磷酸盐缓冲液(pH7.0),洗脱速率为lml/min,洗脱液在280nm处检测,色谱柱温为室温。经验证得知,WGWSP12为一个对称峰,其保留时间为11.84min。The purity of WGWSP12 was identified by SEC-HPLC, using Hitachi high performance liquid phase system and Shodex KW-804 protein column. The elution limit of the column is 1,000,000Da, the separation column efficiency is greater than 20,000Da, the mobile phase is 50mmol/L phosphate buffer (pH7.0), the elution rate is 1ml/min, and the eluent is detected at 280nm. The column temperature is room temperature. It is verified that WGWSP12 is a symmetrical peak with a retention time of 11.84min.
(6)WGWSP12的分子量分布情况(6) Molecular weight distribution of WGWSP12
采用还原和非还原的聚丙烯酰胺凝胶电泳对WGWSP11的分子量进行鉴定,证明WGWSP12为单一的条带,为电泳纯蛋白,分子量约为41kDa。The molecular weight of WGWSP11 was identified by reducing and non-reducing polyacrylamide gel electrophoresis, which proved that WGWSP12 was a single band, an electrophoretic pure protein, with a molecular weight of about 41kDa.
以下结合若干较佳实施例对本发明的技术方案作进一步说明。The technical solution of the present invention will be further described below in conjunction with several preferred embodiments.
实施例1Example 1
将400mL水加入盛有40g脱脂麦胚粉的500mL三角瓶中,在气浴振荡器上以200r/min的速度提取3h,然后10000r/min,4℃,20min离心得到上清液,将残渣用200mL对应溶剂提取1h,相同条件下离心,合并上清液,向其中加入固体硫酸铵63.6g,至饱和度20%,再搅拌40min,静置3h,然后10000r/min,4℃,20min离心,收集上清,继续添加固体硫酸铵72g,至饱和度40%,搅拌40min,静置3h,然后10000r/min,4℃,20min离心,弃去上清液收集沉淀,沉淀加少量水复溶,然后将其装入透析袋中,置于4℃水中透析24h,浓缩后冷冻干燥,制的WGWSP。取220mg小麦胚芽水溶性蛋白冷冻干燥样品(WGWSP),溶解于10mLTris-HCl缓冲液中,加入到DEAE-Sepharose FF离子交换柱中,依次用pH8.0、20mmol/LTris-HCl缓冲液、含0.3mol/LNaCl的Tris-HCl缓冲液和含0.8mol/LNaCl的Tris-HCl缓冲液为洗脱剂进行洗脱,流速为1.6mL/min,收集组分1(WGWSP1)双蒸水透析脱盐,冷冻干燥。取5mg WGWSP1溶解于2mL磷酸盐缓冲液中,加入到Superdex_200凝胶过滤柱中,用磷酸盐缓冲液进行洗脱,收集组分3,双蒸水透析脱盐,冷冻干燥,制备得到WGWSP11。Add 400mL of water into a 500mL Erlenmeyer flask containing 40g of defatted wheat germ powder, extract on an air bath shaker at a speed of 200r/min for 3h, then centrifuge at 10000r/min, 4°C for 20min to obtain a supernatant, and use 200mL corresponds to solvent extraction for 1h, centrifuge under the same conditions, combine the supernatant, add 63.6g of solid ammonium sulfate to 20% saturation, stir for 40min, let stand for 3h, then centrifuge at 10000r/min, 4°C, 20min, Collect the supernatant, continue to add 72g of solid ammonium sulfate until the saturation is 40%, stir for 40min, let it stand for 3h, then centrifuge at 10000r/min, 4°C for 20min, discard the supernatant to collect the precipitate, add a small amount of water to redissolve the precipitate, Then put it into a dialysis bag, dialyze in water at 4°C for 24 hours, concentrate and freeze-dry to prepare WGWSP. Take 220mg of wheat germ water-soluble protein freeze-dried sample (WGWSP), dissolve in 10mL Tris-HCl buffer, add to DEAE-Sepharose FF ion-exchange column, successively use pH8.0, 20mmol/LTris-HCl buffer, containing 0.3 mol/L NaCl Tris-HCl buffer and 0.8 mol/L NaCl-containing Tris-HCl buffer were used as eluents for elution, the flow rate was 1.6 mL/min, the collected fraction 1 (WGWSP1) was desalted by double distilled water dialysis, frozen dry. 5 mg of WGWSP1 was dissolved in 2 mL of phosphate buffer, added to a Superdex_200 gel filtration column, eluted with phosphate buffer, and fraction 3 was collected, desalted by double-distilled water dialysis, and freeze-dried to prepare WGWSP11.
通过此方法制得的小麦胚芽抗肿瘤蛋白WGWSP11白色絮状,相对分子质量约为41kDa,对人乳腺癌细胞株MDA-MB231的生长有显著的增殖抑制活性,IC50值为22.33μg/mL,对正常细胞人胚肾细胞毒性很小,人胚肾细胞的IC50值为191.72μg/mL。The wheat germ anti-tumor protein WGWSP11 prepared by this method is white flocculent, with a relative molecular mass of about 41kDa, and has significant proliferation inhibitory activity on the growth of human breast cancer cell line MDA-MB231, with an IC50 value of 22.33 μg/mL. Human embryonic kidney cytotoxicity of normal cells is very small, and the IC50 value of human embryonic kidney cells is 191.72 μg/mL.
实施例2Example 2
将2000mL水加入盛有200g脱脂麦胚粉的2500mL三角瓶中,在气浴振荡器上以200r/min的速度提取3h,然后10000r/min,4℃,20min离心得到上清液,将残渣用1000mL对应溶剂提取1h,相同条件下离心,合并上清液,向其中加入固体硫酸铵318g,至饱和度20%,再搅拌40分钟,静置3h,然后10000r/min,4℃,20min离心,收集上清,继续添加固体硫酸铵360g,至饱和度40%,再搅拌40分钟,静置3h,然后10000r/min,4℃,20min离心,弃去上清液收集沉淀,沉淀加少量水复溶,然后将其装入透析袋中,置于4℃水中透析24h,浓缩后冷冻干燥,制的WGWSP。取180mg小麦胚芽水溶性蛋白冷冻干燥样品(WGWSP),溶解于5mLTris-HCl缓冲液中,加入到DEAE-Sepharose FF离子交换柱中,依次用pH8.0、20mmol/LTris-HCl缓冲液、含0.3mol/LNaCl的Tris-HCl缓冲液和含0.8mol/LNaCl的Tris-HCl缓冲液为洗脱剂进行洗脱,流速为1.6mL/min,收集组分1(WGWSP1)双蒸水透析脱盐,冷冻干燥。取9mg WGWSP1溶解于3mL磷酸盐缓冲液中,加入到Superdex_200凝胶过滤柱中,用磷酸盐缓冲液进行洗脱,收集组分3,双蒸水透析脱盐,冷冻干燥,制备得到WGWSP11。Add 2000mL water into a 2500mL Erlenmeyer flask containing 200g defatted wheat germ powder, extract on an air bath shaker at a speed of 200r/min for 3h, then centrifuge at 10000r/min, 4°C for 20min to obtain a supernatant, and use 1000mL corresponds to solvent extraction for 1h, centrifuge under the same conditions, combine the supernatant, add 318g of solid ammonium sulfate to 20% saturation, stir for 40 minutes, let stand for 3h, then centrifuge at 10000r/min, 4°C, 20min, Collect the supernatant, continue to add 360g of solid ammonium sulfate until the saturation is 40%, stir for another 40 minutes, let stand for 3h, then centrifuge at 10000r/min, 4°C for 20min, discard the supernatant to collect the precipitate, and add a small amount of water to the precipitate to reconstitute Then put it into a dialysis bag, dialyze in water at 4°C for 24 hours, concentrate and freeze-dry to prepare WGWSP. Take 180mg of wheat germ water-soluble protein freeze-dried sample (WGWSP), dissolve in 5mL Tris-HCl buffer, add to DEAE-Sepharose FF ion-exchange column, use pH8.0, 20mmol/LTris-HCl buffer, containing 0.3 mol/L NaCl Tris-HCl buffer and 0.8 mol/L NaCl-containing Tris-HCl buffer were used as eluents for elution, the flow rate was 1.6 mL/min, the collected fraction 1 (WGWSP1) was desalted by double-distilled water dialysis, and frozen dry. 9 mg of WGWSP1 was dissolved in 3 mL of phosphate buffer, added to a Superdex_200 gel filtration column, eluted with phosphate buffer, fraction 3 was collected, desalted by double-distilled water dialysis, and freeze-dried to prepare WGWSP11.
需要指出的是,以上所述仅为本发明的优选实施例,并不用于限制本发明,对于本领域的技术人员来说,凡在本发明的精神和原则之内,所作的任何修改、改进等,均应包括在本发明的保护范围之内。It should be pointed out that the above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, any modifications and improvements made within the spirit and principles of the present invention etc., should be included within the protection scope of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310046768.8A CN103087169B (en) | 2013-02-05 | 2013-02-05 | Preparation method of antitumor wheat germ proteins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310046768.8A CN103087169B (en) | 2013-02-05 | 2013-02-05 | Preparation method of antitumor wheat germ proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103087169A CN103087169A (en) | 2013-05-08 |
CN103087169B true CN103087169B (en) | 2015-03-11 |
Family
ID=48200338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310046768.8A Expired - Fee Related CN103087169B (en) | 2013-02-05 | 2013-02-05 | Preparation method of antitumor wheat germ proteins |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103087169B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103626847B (en) * | 2013-11-15 | 2015-11-04 | 江南大学 | A kind of wheat germ protein source zinc chelating peptide and its preparation method |
CN104497101B (en) * | 2015-01-16 | 2017-11-03 | 北京七巧时代科技有限公司 | A kind of preparation method of wheat embryo cytoactive albumen |
CN104788541B (en) * | 2015-05-07 | 2018-08-10 | 南京财经大学 | Small peptide, preparation method and applications with antioxidant activity |
CN105724725B (en) * | 2016-02-02 | 2019-05-21 | 中国农业科学院麻类研究所 | The extracting method of dish jute germ protein |
CN107007826B (en) * | 2017-04-19 | 2020-03-31 | 南京中医药大学 | Active protein of isatis root and its preparing process and application |
CN108384743A (en) * | 2018-03-03 | 2018-08-10 | 河南工业大学 | A kind of preparation method of cereal embryo source active component nano-scale excretion body |
CN110590922B (en) * | 2019-10-15 | 2022-04-22 | 南开大学 | Antitumor protein extract in red onion bacteria, and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174443B1 (en) * | 1997-04-14 | 2001-01-16 | The Research Foundation Of State University Of New York | Purification of wheat germ agglutinin using macroporous or microporous filtration membrane |
CN1944456A (en) * | 2006-10-24 | 2007-04-11 | 江南大学 | Process for preparing duck wheat anti-tumor protein |
CN102524514A (en) * | 2012-01-18 | 2012-07-04 | 安徽燕之坊食品有限公司 | Preparation method for active polypeptide of wheat germ |
WO2012159988A1 (en) * | 2011-05-20 | 2012-11-29 | 3Ch Ltd | Use of fermented wheat germ in the treatment of inflammatory bowel disease |
-
2013
- 2013-02-05 CN CN201310046768.8A patent/CN103087169B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174443B1 (en) * | 1997-04-14 | 2001-01-16 | The Research Foundation Of State University Of New York | Purification of wheat germ agglutinin using macroporous or microporous filtration membrane |
CN1944456A (en) * | 2006-10-24 | 2007-04-11 | 江南大学 | Process for preparing duck wheat anti-tumor protein |
WO2012159988A1 (en) * | 2011-05-20 | 2012-11-29 | 3Ch Ltd | Use of fermented wheat germ in the treatment of inflammatory bowel disease |
CN102524514A (en) * | 2012-01-18 | 2012-07-04 | 安徽燕之坊食品有限公司 | Preparation method for active polypeptide of wheat germ |
Non-Patent Citations (1)
Title |
---|
脱脂麦胚提取物抗氧化抗肿瘤活性的研究;连彩霞;《江南大学硕士论文》;20110824;第8页第2.3.1节 * |
Also Published As
Publication number | Publication date |
---|---|
CN103087169A (en) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103087169B (en) | Preparation method of antitumor wheat germ proteins | |
CN102936292B (en) | Preparation method of lycium barbarum polysaccharide having high antioxidant activity | |
CN102399297A (en) | A kind of enteromorpha polysaccharide with immune activity and preparation method thereof | |
CN103204906A (en) | Mussel meat protein antioxidative peptide and preparation method thereof | |
US10835552B2 (en) | Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharide | |
CN103254324A (en) | Method for extracting antioxidant polysaccharide of kelp | |
CN112010989B (en) | A kind of preparation method of P. chinensis polysaccharide with antioxidant activity | |
CN107163162A (en) | A kind of refined method of LBP-X | |
CN110256598A (en) | A kind of preparation method of difference bioactivity lentinan | |
CN110916198A (en) | A method for simultaneously preparing pectin polysaccharide and viscous glycoprotein by utilizing okra fermented wine residue | |
CN111072752B (en) | A kind of preparation method and product with polypeptide for promoting human skin cell proliferation and application thereof | |
CN108265092B (en) | A kind of mushroom oligosaccharide with excellent antioxidant activity and preparation method thereof | |
CN104152518B (en) | Preparation method of hepatopathy complementary-food cod skin collagen peptide | |
CN109293791B (en) | Lepista nuda water-soluble polysaccharide and preparation method and application thereof | |
CN104817646B (en) | Polysaccharide and its extracting method and application in ganoderma capense | |
CN104211754B (en) | A kind of method preparing polysaccharide and glycoprotein the stem from alfalfa | |
CN110343156B (en) | Extraction and purification method of black bean glycoprotein | |
CN105294878B (en) | A kind of ramulus mori antitumor activity polysaccharide RMPW 1 preparation method | |
CN106480148A (en) | A kind of preparation method of chilli seed antibacterial peptide | |
CN102050882A (en) | Longan proteoglycan as well as preparation method and application thereof | |
CN100537597C (en) | A kind of preparation method of tartary buckwheat anti-tumor protein | |
KR100623001B1 (en) | Batch Separation and Purification Method of Laminaran and Hucoidan for Food Materials with Anticancer and Antihyperlipidemic Activity from Brown Algae | |
CN105017201B (en) | A kind of preparation method of pure natural Ligustrum quihoui fruit anthocyanidin | |
CN114685694A (en) | A kind of water bamboo neutral polysaccharide and preparation method thereof | |
WO1998027992A1 (en) | Antitumor active substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 |
|
CF01 | Termination of patent right due to non-payment of annual fee |